Instance: Oxascand-15mg-Tablet-SE-IS-RegulatedAuthorization
InstanceOf: PPLRegulatedAuthorization
Usage: #inline
* meta.versionId = "2"
* meta.lastUpdated = "2022-10-10T06:42:47.931+00:00"
* identifier.system = "http://ema.europa.eu/fhir/marketingAuthorizationNumber"
* identifier.value = "11083"
* subject = Reference(Oxascand-15mg-Tablet-SE-IS-MedicinalProductDefinition)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000535 "Sweden"
* status = $100000072049#100000072099 "Valid"
* statusDate = "1990-02-02"
* holder.identifier.system = "https://spor.ema.europa.eu/v1/locations"
* holder.identifier.value = "LOC-100001602"
* holder.display = "Teva Sweden AB"
* case.type = $authorisationDateType#dateOfFirstAuthorisation "First Authorisation"
* case.dateDateTime = "1990-02-02"